LivaNova (LIVN) Current Deferred Tax Assets (2015)

LivaNova's (LIVN) quarterly Current Deferred Tax Assets came in at $4.4 million in Q4 2015, down 39.14% quarter-over-quarter from $7.2 million in Q2 2015.

LivaNova (LIVN) Current Deferred Tax Assets (2015) Analysis & Trends

LivaNova has disclosed Current Deferred Tax Assets across 1 years of filings, most recently posting $4.4 million for Q4 2015.

  • Current Deferred Tax Assets for Q4 2015 came in at $4.4 million, changed N/A year-over-year; the trailing twelve-month figure through Oct 2015 was $4.4 million (changed N/A YoY), and the FY2015 annual result was $7.2 million, changed N/A from the prior year.
  • Current Deferred Tax Assets came in at $4.4 million for Q4 2015 at LivaNova, down from $7.2 million in the prior quarter.
  • In the past five years, Current Deferred Tax Assets ranged from a high of $7.2 million in Q2 2015 to a low of $4.4 million in Q4 2015.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 154.42 Bn 147.76 Bn 6.27 Bn
2 Stryker 118.12 Bn 115.25 Bn 3.81 Bn
3 Medtronic 101.72 Bn 93.55 Bn 5.76 Bn
4 Boston Scientific 67.19 Bn 65.98 Bn 3.61 Bn
5 Edwards Lifesciences 50.69 Bn 47.02 Bn 1.29 Bn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn
7 Dexcom 28.09 Bn 26.97 Bn 750.30 Mn
8 GE HealthCare Technologies 28.08 Bn 26.02 Bn 1.98 Bn
9 Steris 19.80 Bn 19.37 Bn 697.10 Mn
10 LivaNova 4.29 Bn 3.71 Bn 243.75 Mn

Historic Data

Download Data
DateValue
Oct 18, 2015 4.38 Mn
Oct 18, 2015 4.38 Mn
Apr 24, 2015 7.20 Mn
Apr 24, 2015 7.20 Mn